Our research proved that HJRG can effectively reduce the liver damage and oxidative stress caused by CCl4, and the mechanism may be the inhibition of TNFR1-mediated MAPK and NF-κB signaling pathways to reduce the inflammatory response, thereby inhibiting liver fibrosis. The gene discussed is NFKB1; the disease is Hepatic fibrosis.